Literature DB >> 11175182

Tissue Doppler to Assess Diastolic Left Ventricular Function.

Mario J. Garcia1, James D. Thomas.   

Abstract

Doppler indices of left ventricular (LV) filling have been used traditionally for the assessment of LV diastolic function. In many circumstances, however, the interpretation of these indices is difficult because they respond to alterations of different physiological variables such as preload, relaxation, and heart rate. A typical example of their limitation is seen in patients with abnormal LV relaxation and increased preload compensation, who often present a "pseudonormal" LV filling pattern. Thus, there is a need for noninvasive indices of diastolic function capable of discriminating the effects of relaxation and preload. Tissue Doppler echocardiography (TDE) is available in most modern cardiac ultrasound imaging systems. TDE can be used to obtain regional myocardial velocities during isovolumic relaxation, early filling, and atrial systole with high spatial and temporal resolution. This article discusses the complementary role, limitations, and future challenges of TDE in the study of diastolic function.

Entities:  

Year:  1999        PMID: 11175182     DOI: 10.1111/j.1540-8175.1999.tb00097.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  3 in total

1.  [A structured report data set for documentation of echocardiographic studies--Update 2004].

Authors:  W Voelker
Journal:  Z Kardiol       Date:  2004-12

2.  Noninvasive evaluation of left ventricular noncompaction: what's new in 2009?

Authors:  Benjamin W Eidem
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

3.  Left ventricle diastolic function in the patients after coronary arteries bypass graft combined with left ventricle aneurismectomy according to tissue doppler imaging: one year follow-up.

Authors:  Maryna N Dolzhenko; S A Rudenko; S V Potashev; T V Simagina; N N Nosenko; T G Kravchenko
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.